Myeloid Leukemias Active Not Recruiting Phase 1 Trials for Antithymocyte immunoglobulin (rabbit) (DB00098)

Back to Myeloid Leukemias

Also known as: Leukemia, Myeloid / Myeloid leukaemia / Myeloid Leukemia / Leukemia myeloid / Non-lymphoblastic leukaemia NOS / Leukemic granulocytic / Non-lymphoblastic leukemia NOS / Unspecified myeloid leukaemia / Unspecified myeloid leukemia / Leukaemia myelogenous / Leukemia myelogenous / Myelocytic leukaemia / Myelocytic leukemia / Leukemia granulocytic NOS / Leukaemia granulocytic NOS / Leukaemia granulocytic / Leukemia granulocytic / Leukaemia myeloid / Myeloid leukemia NOS / Myeloid leukaemia NOS

Indication	Status	Phase
DBCOND0042450 (Myeloid Leukemias)	Active Not Recruiting	1

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT02916979	Myeloid-Derived Suppressor Cells and Checkpoint Immune Regulators' Expression in Allogeneic SCT Using FluBuATG	Treatment	Antithymocyte immunoglobulin (rabbit) (DB00098) Busulfan (DB01008) Fludarabine (DB01073) Methotrexate (DB00563)